CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
pmid: 12429347
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
Published cDNA sequences suggest the existence of non-synonymous single nucleotide polymorphisms in the cytochrome P450 CYP2C8. To determine whether these polymorphisms could be confirmed in a Caucasian population and to investigate whether additional polymorphisms occur in the coding and upstream regions of this gene, we screened for previously described and for novel polymorphisms using PCR-RFLP and SSCP analysis. We confirmed the existence of two of the previously detected polymorphisms which give rise to the amino acid substitutions I264M and K399R, respectively, but failed to detect three others in our population. We also confirmed that a recently identified polymorphism (R139K) is linked to K399R (CYP2C8*3) in our study population. The allele frequencies for the I264M (CYP2C8*4 allele) and the CYP2C8*3 allele were 0.075 and 0.15, respectively. Three novel polymorphisms (T-370G, C-271A and T1196C/L390S) were also detected with the upstream polymorphisms showing allele frequencies of 0.061 and 0.196, respectively, but the L390S polymorphism detected only in a single subject. An additional single subject was heterozygous for a polymorphism recently described in African-Americans (A805T; CYP2C8*2 allele). The functional significance of the two upstream polymorphisms and the CYP2C8*3 and CYP2C8*4 alleles was investigated in human liver microsomes. Samples heterozygous for CYP2C8*3 showed significantly lower paclitaxel 6alpha-hydroxylase activity compared with wild-type samples. Median activity associated with CYP2C8*4 also appeared lower than the wild-type but the difference was not significant. There was no evidence that either upstream polymorphism gave rise to altered CYP2C8 expression.
- Newcastle University United Kingdom
- Janssen (Belgium) Belgium
- Janssen Pharmaceutica Belgium
- University of Newcastle Australia Australia
DNA, Complementary, Paclitaxel, Sequence Homology, Amino Acid, Molecular Sequence Data, Polymorphism, Single Nucleotide, White People, Cytochrome P-450 CYP2C8, Microsomes, Liver, Humans, Amino Acid Sequence, Aryl Hydrocarbon Hydroxylases, Polymorphism, Single-Stranded Conformational
DNA, Complementary, Paclitaxel, Sequence Homology, Amino Acid, Molecular Sequence Data, Polymorphism, Single Nucleotide, White People, Cytochrome P-450 CYP2C8, Microsomes, Liver, Humans, Amino Acid Sequence, Aryl Hydrocarbon Hydroxylases, Polymorphism, Single-Stranded Conformational
4 Research products, page 1 of 1
- 2020IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2012IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).222 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
